首页> 美国卫生研究院文献>Thoracic Cancer >Blood T cell diversity associated with the prognosis of advanced non‐small cell lung carcinoma treated with first‐line pemetrexed based chemotherapy

【2h】

Blood T cell diversity associated with the prognosis of advanced non‐small cell lung carcinoma treated with first‐line pemetrexed based chemotherapy

机译：血液T细胞多样性与先进的非小细胞肺癌的预后相关用一线培养基基化疗治疗

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
引文网络
相似文献
相关主题

摘要

The tumor microenvironment is associated with prognosis in advanced non‐small cell lung carcinoma (NSCLC). The aim of this study was to explore the relationship between blood T cell diversity and survival of patients treated with pemetrexed‐based chemotherapy for nonsquamous NSCLC.

机译：肿瘤微环境与晚期非小细胞肺癌（NSCLC）的预后有关。本研究的目的是探讨血液T细胞多样性与患者的血液多样性与基于Pemetrexed基化学疗法的患者的关系。

著录项

期刊名称 Thoracic Cancer
作者
Li Qian; Zhang Zhaohui; Xu Yaping; Liu Zhentian; Liu Zhentao; Wang Qiqi; Gu Yangchun; Liu Yane; Yin Wencheng; Yi Fumei; Yao Yanhong; Cao Baoshan; Liang Li;
展开▼
作者单位

展开▼
年(卷),期 2021(12),7
年度 2021
页码 997–1005
总页数 9
原文格式 PDF
正文语种
中图分类肿瘤学;
关键词

机译：先进的非小细胞肺癌;T细胞多样性;肿瘤微环境;

相似文献

外文文献
中文文献
专利

1. Blood T cell diversity associated with the prognosis of advanced non‐small cell lung carcinoma treated with first‐line pemetrexed based chemotherapy [J] . Li Qian, Zhang Zhaohui, Xu Yaping, Thoracic cancer. . 2021,第7期

机译：血液T细胞多样性与先进的非小细胞肺癌预后，用一线培养基型化疗治疗先进的非小细胞肺癌
2. Efficacy of Pemetrexed-based Chemotherapy in Comparison to Non-Pemetrexed-based Chemotherapy in Advanced, ALK+ Non-Small Cell Lung Cancer [J] . Jo Jaemin, Kim Se Hyun, Kim Yu Jung, Yonsei Medical Journal . 2018,第2期

机译：培美曲塞为基础的化疗与非培美曲塞为基础的化疗在晚期ALK +非小细胞肺癌中的疗效比较
3. Outcomes of patients in the North Trent region with advanced non-small-cell lung cancer treated with maintenance pemetrexed following induction with platinum non-pemetrexed doublet chemotherapy [J] . Marshall R., Kakoudaki M., Danson S. J., Lung cancer: Journal of the International Association for the Study of Lung Cancer . 2017,第Suppla1期

机译：北支手区患者的结果，采用先进的非小细胞肺癌治疗，用铂非培养型双胞盆化疗进行诱导后进行维持培养。
4. Pemetrexed versus docetaxel single agent chemotherapy in chemotherapy-naive elderly patients with advanced non-small cell lung cancer [C] . Hua Xin, Zhenguo Han, Haibo Huang 2011 International Conference on Human Health and Biomedical Engineering . 2011

机译：培美曲塞与多西他赛单药化疗在未接受化疗的老年晚期非小细胞肺癌患者中的作用
5. Gene expression analysis of human non -small cell lung cancer subtypes, adenocarcinoma and squamous cell carcinoma, and mouse lung epithelial cell lines: Implications in lung tumorigenesis [D] . Silvers, Amy Lynn. 2002

机译：人类非小细胞肺癌亚型，腺癌和鳞状细胞癌以及小鼠肺上皮细胞系的基因表达分析：在肺肿瘤发生中的意义
6. Efficacy of Pemetrexed-based Chemotherapy in Comparison to Non-Pemetrexed-based Chemotherapy in Advanced ALK+ Non-Small Cell Lung Cancer [O] . Jaemin Jo, Se Hyun Kim, Yu Jung Kim, 2018

机译：培美曲塞为基础的化疗与非培美曲塞为基础的化疗在晚期ALK +非小细胞肺癌中的疗效比较
7. P2-328: Is pemetrexed more effective in adenocarcinoma and large cell lung cancer than in squamous cell carcinoma? A retrospective analysis of a phase III trial of pemetrexed vs docetaxel in previously treated patients with advanced non-small cell lung cancer (NSCLC) [O] . Peterson Patrick, Park Keunchil, Fossella Frank, 2007

机译：P2-328：培美曲塞在腺癌和大细胞肺癌中是否比鳞状细胞癌更有效？培美曲塞与多西他赛在先前治疗的晚期非小细胞肺癌（NSCLC）患者中进行的III期临床试验的回顾性分析

Blood T cell diversity associated with the prognosis of advanced non‐small cell lung carcinoma treated with first‐line pemetrexed based chemotherapy

摘要

著录项

引文网络

相似文献

相关主题

期刊订阅